Experts: Diversity key in clinical trials
Blacks are underrepresented in the latest COVID-19 clinical trials, compared to their share of the U.S. population, and Latinos and Asians are underrepresented in one, according to data from the companies developing the vaccines. Credit: Newsday / Alejandra Villa; Johnny Milano